President Donald Trump walks past HHS secretary Alex Azar (Saul Loeb/AFP via Getty Images)
October 6, 2020 07:58 AM EDTUpdated 03:17 PM
FDA+
Coronavirus

Trump of­fi­cials said in­dus­try did­n't want FDA's stricter vac­cine guid­ance, but the lead­ing de­vel­op­er says they nev­er dis­cussed it

Arsalan Arif

Founder

Jason Mast

Editor

There are four weeks to the elec­tion. Se­nior Trump of­fi­cials are now cit­ing in­dus­try op­po­si­tion as the rea­son they are block­ing the FDA from mak­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times